Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Polarean ImagingPLLWF +560.00% Days Sales Outstanding is 102.91 as of Jun. 2025, which is 155% above its 10-year median of 40.28. The stock has 4 warning signs investors should review.
Polarean Imaging (OTCPK:PLLWF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Polarean Imaging Days Sales Outstanding Related Terms
Polarean Imaging Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Polarean Imaging's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLLWF vs FOFA, BTCY, LFWD: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Polarean Imaging's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Days Sales Outstanding falls into.
Polarean Imaging Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 102.91 mean?
Polarean Imaging (PLLWF) has a Days Sales Outstanding of 102.91 as of Jun. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Polarean Imaging and its competitors. This is 155% above median its historical median of 40.28. Over the past decade, Polarean Imaging's Days Sales Outstanding has ranged from 1.77 to 110.33.
Is Polarean Imaging's Days Sales Outstanding too high?
Polarean Imaging's current Days Sales Outstanding of 102.91 is 155% above median its 10-year median of 40.28. Over the past 10 years, this metric has ranged from a low of 1.77 to a high of 110.33. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.46. Polarean Imaging's value of 102.91 is 57.2% above this industry median.
How does Polarean Imaging's Days Sales Outstanding compare to FOFA and BTCY?
Polarean Imaging's Days Sales Outstanding of 102.91 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Sales Outstanding is 65.46. Polarean Imaging's value of 102.91 is 57.2% above this benchmark. Historically, Polarean Imaging's own Days Sales Outstanding has ranged from 1.77 to 110.33 over the past decade. While the company's 10-year median is 40.28 vs. the industry median of 65.46, Polarean Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.46, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current Days Sales Outstanding of 102.91 is 57.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current Days Sales Outstanding is 102.91, which is 155% above median its own 10-year median of 40.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current Days Sales Outstanding of 102.91. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current Days Sales Outstanding is 102.91, which is 155% above median its 10-year median of 40.28 and 57.2% above the Medical Devices & Instruments industry median of 65.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current Days Sales Outstanding is 102.91 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLLWF has been successfully added to your 
